1. Home
  2. |Insights
  3. |C5's 4th Annual Conference on 'Pharma & Biotech Patent Litigation'

C5's 4th Annual Conference on 'Pharma & Biotech Patent Litigation'

Event | 01.31.12 - 02.01.12, 12:00 AM UTC - 12:00 AM UTC

C5’s 4th Annual Forum on Pharma & Biotech Patent Litigation brings together key regulators and judicial authorities, distinguished in-house counsel from the world’s largest pharma and biotech companies, and their expert legal advisors from across Europe and the US. Based on their first-hand experience in recent pharma and biotech patent litigation, the expert panel will provide you with important case law updates and invaluable strategies to combat the latest challenges.


Sean-Paul Brankin will speak on "Disclosure of Prior Art and Forthcoming Antitrust Issues."

Insights

Event | 12.04.25

ACI 30th Annual Conference on Drug & Medical Device Litigation

Dan Campbell with Speak on the panel "Mastering MDL Case Management: What Proposed Rule 16.1 Really Means for Consolidated Litigation."
Rule 16.1 attempts to guide early case management in MDLs, impacting litigation pace and costs. Permissive language like “should” instead of “must”, could lead to inconsistent applications. This panel will explore the rule’s anticipated impact and implications for procedures.